For example, in breast cancer, DRD1 agonists have been shown to inhibit breast cancer cell growth in vitro [23, 24], reduce cancer stemness and cell mobility in vitro [25], and reduce tumor growth [23] and lung metastasis [25] in vivo. The gene discussed is DRD1; the disease is neoplasm.